» Articles » PMID: 35878128

Estimation of Excess All-Cause Mortality Due to COVID-19 in Thailand

Overview
Date 2022 Jul 25
PMID 35878128
Authors
Affiliations
Soon will be listed here.
Abstract

Thailand has experienced the most prominent COVID-19 outbreak in 2021, resulting in a new record for COVID-19 cases and deaths. To assess the influence of the COVID-19 outbreak on mortality, we estimated excess all-cause and pneumonia mortality in Thailand during the COVID-19 outbreak from April to October 2021. We used mortality from the previous 5 years to estimate the baseline number of deaths using generalized linear mixed models. The models were adjusted for seasonality and demographics. We found that, during the outbreak in 2021, there was a significant rise in excess fatalities, especially in the older age groups. The estimated cumulative excess death was 14.3% (95% CI: 8.6-18.8%) higher than the baseline. The results also showed that the excess deaths in males were higher than in females by approximately 26.3%. The excess deaths directly caused by the COVID-19 infections accounted for approximately 75.0% of the all-cause excess deaths. Furthermore, excess pneumonia deaths were also found to be 26.2% (95% CI: 4.8-46.0%) above baseline.

Citing Articles

Excess mortality due to COVID-19 in Thailand between the pandemic and post-pandemic periods.

Dul-Amnuay A, Peansukwech U, Hanapun C, Sharma A Sci Rep. 2025; 15(1):957.

PMID: 39762415 PMC: 11704259. DOI: 10.1038/s41598-025-85324-4.


Impact of COVID-19 Vaccination in Thailand: Averted Deaths and Severe Infections Across Age Groups.

Wilasang C, Suttirat P, Wannigama D, Amarasiri M, Chadsuthi S, Modchang C Trop Med Infect Dis. 2024; 9(12).

PMID: 39728813 PMC: 11679040. DOI: 10.3390/tropicalmed9120286.


Mixed effects modelling of excess mortality and COVID-19 lockdowns in Thailand.

De Padua Durante A, Lacaza R, Lapitan P, Kochhar N, Tan E, Thomas M Sci Rep. 2024; 14(1):8240.

PMID: 38589527 PMC: 11001903. DOI: 10.1038/s41598-024-58358-3.


Governance, policy, and health systems responses to the COVID-19 pandemic in Thailand: a qualitative study.

Tuangratananon T, Rajatanavin N, Khuntha S, Rittimanomai S, Asgari-Jirhandeh N, Tangcharoensathien V Front Public Health. 2024; 12:1250192.

PMID: 38584930 PMC: 10996397. DOI: 10.3389/fpubh.2024.1250192.


All-cause excess mortality among end-stage renal disease (ESRD) patients during the COVID-19 pandemic in Thailand: a cross-sectional study from a national-level claims database.

Jirapanakorn S, Witthayapipopsakul W, Kusreesakul K, Lakhotia D, Tangcharoensathien V, Suphanchaimat R BMJ Open. 2024; 14(1):e081383.

PMID: 38272543 PMC: 10824030. DOI: 10.1136/bmjopen-2023-081383.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Wilasang C, Jitsuk N, Sararat C, Modchang C . Reconstruction of the transmission dynamics of the first COVID-19 epidemic wave in Thailand. Sci Rep. 2022; 12(1):2002. PMC: 8821624. DOI: 10.1038/s41598-022-06008-x. View

3.
Modig K, Ahlbom A, Ebeling M . Excess mortality from COVID-19: weekly excess death rates by age and sex for Sweden and its most affected region. Eur J Public Health. 2020; 31(1):17-22. PMC: 7717265. DOI: 10.1093/eurpub/ckaa218. View

4.
Aksoyalp Z, Nemutlu-Samur D . Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms. Eur J Pharmacol. 2021; 912:174548. PMC: 8486578. DOI: 10.1016/j.ejphar.2021.174548. View

5.
Ribas Freitas A, Cavalcanti L, Von Zuben A, Donalisio M . Excess Mortality Related to Chikungunya Epidemics in the Context of Co-circulation of Other Arboviruses in Brazil. PLoS Curr. 2017; 9. PMC: 5731794. DOI: 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884. View